Syk kinase inhibitors for rheumatoid arthritis: trials and tribulations.

Abstract

In the last 20 years, the outlook for rheumatoid arthritis (RA) patients has improved substantially. Wilske and Healey (1) initiated the paradigm shift of reversing the therapeutic pyramid. They made the case that the disease should be hit hard in its initial stages, when a window of opportunity (2) might exist to prevent the damage and severe disability of… (More)
DOI: 10.1002/art.30109

Cite this paper

@article{Boers2011SykKI, title={Syk kinase inhibitors for rheumatoid arthritis: trials and tribulations.}, author={Maarten Boers}, journal={Arthritis and rheumatism}, year={2011}, volume={63 2}, pages={329-30} }